Journal of Clinical Oncology · 2004 · 112 citations · 41 references
MedicineGeneticsOncologyCancer GeneticsMolecular OncologyNeoplasiaBreast Cancer OncologyBreast PathologyNext-generation Sequencing In OncologyBrca MutationsBreast Cancer HistoryBreast Cancer Molecular SubtypesFounder MutationsImmunohistochemical DetectionImmunohistochemical MarkersImmunohistochemical StainingMissense Mutations
PURPOSE: The prevalence of BRCA-associated breast carcinoma in the Korean population has not been evaluated extensively. METHODS: Sixty Korean women who developed breast cancer by age 40 years were studied. Lymphocyte specimens from peripheral blood were processed for BRCA1 and BRCA2 by complete sequencing. Family history through three generations was obtained. Available paraffin-embedded tissue blocks were processed for immunohistochemical staining. RESULTS: In the cohort of 60 patients, nine patients with 11 deleterious mutations (six in BRCA1 and five in BRCA2) and seven missense mutations of unknown significance were found. Two patients had deleterious mutations in both BRCA1 and BRCA2 (double mutant). One half of the mutations were novel, and no founder mutations were observed in this cohort. Most of the BRCA-associated patients had no family history of breast and/or ovarian cancer. The expression of HER-2/neu, cyclin D1, and hormone receptors was less common, and p53 overexpression was more common in BRCA-associated tumors. CONCLUSION: The prevalence of BRCA1 and BRCA2 mutations in Korean women with breast cancer at a young age was high. However, the penetrance, as evidenced by the low frequency of breast and ovarian cancers in family members, appears to be low. These data suggest that there may be different genetic and etiologic factors affecting transmission and penetrance of the BRCA genes in Korean patients with breast cancer diagnosed at a young age.
41
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene <i>BRCA1</i>
Yoshio Miki, Jeffrey Swensen, Donna Shattuck-Eidens et al. · Science · 1994 · 6.1K citations
Robert T. Greenlee, Thomas S. Murray, S. Bolden et al. · CA A Cancer Journal for Clinicians · 2000 · 3.9K citations · Full text
Identification of the breast cancer susceptibility gene BRCA2
Richard Wooster, Graham R. Bignell, Jonathan Lancaster et al. · Nature · 1995 · 3.7K citations